Colfax $287.3 million secondary offering
We advised certain selling stockholders on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Novo Nordisk acquisition of Neotope Neuroscience
We advised Novo Nordisk on the acquisition
Novo Holdings investment in Availity
We advised Availity on the investment
Mathys sale to DJO
We are advising the Mathys family on the sale
Esco Lifesciences $200 million Series A financing
We are advising Esco Lifesciences on its Series A financing
Charles River Laboratories acquisition of Vigene Biosciences
We are advising Charles River on the acquisition
Roivant Sciences combination with Montes Archimedes Acquisition
We are advising Roivant Sciences on its combination with a SPAC
Evernorth acquisition of MDLIVE
We are advising MDLIVE on the transaction
Reckitt Benckiser Group acquisition of Biofreeze
We are advising RB on the acquisition
Charles River Laboratories $875 million acquisition of Cognate
We advised Charles River on the acquisition of a cell and gene therapy contract development and manufacturing organization